Nuclear morphometry and molecular biomarkers of actinic keratosis, sun-damaged, and nonexposed skin
- PMID: 15598753
Nuclear morphometry and molecular biomarkers of actinic keratosis, sun-damaged, and nonexposed skin
Abstract
Computer-assisted image analysis is useful for quantifying the histologic and molecular changes of sun-induced squamous cell carcinoma progression. We used the CAS 200 image analysis system to measure nuclear morphometric parameters, p53 expression, and proliferation markers in actinic keratosis (AK), sun-exposed, and normal skin in 51 patients. Nuclear morphometry revealed significant increases in nuclear absorbance, irregularity of nuclear shape, and nuclear size in AK compared with normal and sun-damaged skin. These parameters showed significantly greater variability in AK nuclei. Argyrophyllic nucleolar organizer area and number were also significantly greater in AK compared with sun-damaged skin and normal skin. Ki67 and p53 expressions were both increased in sun-damaged skin relative to normal and greater still in AK. These data are evidence that sun damage induces proliferation and p53 abnormalities before the appearance of nuclear abnormalities and their associated DNA instability. Following these changes during a skin cancer chemopreventative trial can then help assess the efficacy of the agent and help determine where in the progression of neoplastic changes it exerts its biological effects.
Similar articles
-
Reproducibility and expression of skin biomarkers in sun-damaged skin and actinic keratoses.Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1841-8. doi: 10.1158/1055-9965.EPI-06-0378. Epub 2006 Oct 4. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 17021352 Clinical Trial.
-
Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin.Cancer Epidemiol Biomarkers Prev. 1997 Aug;6(8):583-7. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9264270
-
Expression of p53 in the evolution of squamous cell carcinoma: correlation with the histology of the lesion.J Am Acad Dermatol. 2007 Oct;57(4):669-76. doi: 10.1016/j.jaad.2007.04.025. J Am Acad Dermatol. 2007. PMID: 17870432
-
Actinic keratosis: the key event in the evolution from photoaged skin to squamous cell carcinoma. Therapy based on pathogenetic and clinical aspects.Skin Pharmacol Physiol. 2004 Mar-Apr;17(2):67-76. doi: 10.1159/000076016. Skin Pharmacol Physiol. 2004. PMID: 14976383 Review.
-
The development of actinic keratosis into invasive squamous cell carcinoma: evidence and evolving classification schemes.Clin Dermatol. 2004 May-Jun;22(3):189-96. doi: 10.1016/j.clindermatol.2003.12.006. Clin Dermatol. 2004. PMID: 15262304 Review.
Cited by
-
Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia.Cancer Prev Res (Phila). 2011 Mar;4(3):354-64. doi: 10.1158/1940-6207.CAPR-10-0098. Cancer Prev Res (Phila). 2011. PMID: 21372035 Free PMC article. Clinical Trial.
-
Thickness of Actinic Keratosis Does Not Predict Dysplasia Severity or P53 Expression.Sci Rep. 2016 Sep 27;6:33952. doi: 10.1038/srep33952. Sci Rep. 2016. PMID: 27670104 Free PMC article.
-
Progression of skin lesions from normal skin to squamous cell carcinoma.Anal Quant Cytol Histol. 2009 Feb;31(1):17-25. Anal Quant Cytol Histol. 2009. PMID: 19320189 Free PMC article.
-
Targeting Biomarkers of Proliferation and Inflammation (Ki67, p53, and COX-2) in Actinic Keratoses with Photodynamic Therapy.Biomedicines. 2025 Jun 17;13(6):1487. doi: 10.3390/biomedicines13061487. Biomedicines. 2025. PMID: 40564206 Free PMC article.
-
From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma.J Clin Invest. 2012 Feb;122(2):464-72. doi: 10.1172/JCI57415. Epub 2012 Feb 1. J Clin Invest. 2012. PMID: 22293185 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous